• Most Popular
  • Most Shared

FDA to review UCB's Cimzia for rheumatoid arthritis

Wed Feb 6, 2008 1:18am EST

Stocks

   

BRUSSELS, Feb 6 (Reuters) - Belgian pharmaceutical group UCB (UCB.BR) said on Wednesday that the U.S. Food and Drug Administration (FDA) agreed to review its Cimzia drug for the treatment of adult patients with active rheumatoid arthritis.

Stocks

UCB has faced delays to secure U.S. and European regulatory approval for Cimzia to treat bowel disorder Crohn's disease. (editing by Elizabeth Fullerton)

Stocks


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets